National Institute Of Allergy And Infectious Diseases
-
Remdesivir helps reduce COVID-19 recovery time: study
The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine. Read MoreJun 4, 2020
-
Inflammation relief: what’s the delay?
New research offers hope for patients needing the anti-inflammatory benefits of glucocorticoids without the adverse side effects associated with them. Read MoreJun 28, 2011